[CITATION][C] Early results of 125I therapy of thyrotoxic Graves' disease

JK Siemsen, MS Wallack, RB Martin… - Journal of Nuclear …, 1974 - Soc Nuclear Med
In an attempt to reduce the high incidence of hypothyroidism following radioiodine treatment
of Graves' disease, 125I was used instead of 131I. The low-energy emissions of 125I …

Long-Term Follow-up Study of Compensated Low-Dose 131I Therapy for Graves' Disease

V Sridama, M McCormick, EL Kaplan… - … England Journal of …, 1984 - Mass Medical Soc
We treated 187 patients who had Graves' disease with low-dose radioactive iodide (131I),
using a protocol that included a compensation for thyroid size. The incidence of early …

The early development of transient and permanent hypothyroidism following radioiodine therapy for hyperthyroid Graves' disease.

NR Peden, IR Hart - Canadian Medical Association Journal, 1984 - ncbi.nlm.nih.gov
The outcome in 110 patients first treated with radioiodine (mean dose 6.56 mCi) for
hyperthyroid Graves' disease in 1980 was reviewed. In 23% of the patients the disease had …

[PDF][PDF] Radioiodine-Induce Hypothyroidism in Graves' Disease: Factors Associated with the Increasing Incidence

AJ Cunnien, ID Hay, CA Gorman… - Journal of Nuclear …, 1982 - Soc Nuclear Med
RESULTS From 1952 to 1977, mean patient age decreased from 56 to 44 yr (Table 2). Sex
ratios varied inconsistently throughout the years; for example, 63% of patients in I952 were …

Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131 iodine activity*. Results from a prospective, randomized, multicentre study

H Peters, C Fischer, U Bogner… - European journal of …, 1995 - Wiley Online Library
The present prospective, randomized, multicentre study was performed to directly compare
for the first time the effectiveness of a standard activity of 555 MBq 131 iodine vs. an activity …

Radioactive Iodine (125I) Therapy for Thyrotoxicosis: Background and Evaluation in 148 Patients

IR McDougall, WR Greig… - New England Journal of …, 1971 - Mass Medical Soc
Abstract 131I therapy of thyrotoxicosis results in an increasing incidence of hypothyroidism
with the passage of time. Conventional methods of reducing this phenomenon have led to …

125I Therapy in Graves' Disease: Long-Term Results in 355 Patients

IR McDougall, WR Greig - Annals of Internal Medicine, 1976 - acpjournals.org
Because of the physical and radiobiologic differences between 125I and 131I, a trial using
125I to treat hyperthyroidism was undertaken in the hope of controlling hyperthyroidism …

Problem of Hypothyroidism after I131 Therapy of Hyperthyroidism

JB Stanbury, LJ DeGroot - New England Journal of Medicine, 1964 - Mass Medical Soc
THE introduction of radioactive iodine into clinical therapeutics in 1941 revolutionized the
treatment of Graves's disease. It is now employed as the primary form of treatment for most of …

GRAVES' DISEASE: TREATMENT WITH RADIOIODINE (I131)

MH Soley, ER Miller, N Foreman - The Journal of Clinical …, 1949 - academic.oup.com
Abstract C ARRIER-FREE I131 has been administered by us to patients with Graves'
disease since August 1944 in order to study primarily: a) the efficiency of I131 as an agent …

OUTCOME FOLLOWING STANDARDIZED 185 MBq DOSE 131I THERAPY FOR GRAVES' DISEASE

AB Watson, BEW Brownlie, CM Frampton… - Clinical …, 1988 - Wiley Online Library
The clinical outcome of 199 patients with Graves' disease treated with standardized 185MBq
131I therapy doses has been analysed. Most patients were controlled with antithyroid drugs …